IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atle Fund Management AB

Q1 2022 Holdings

Filed 2022-05-05 | 12 holdings | $6.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$5.9M28,00099.0%
Mckesson Corp(MCK)COM58155Q103$9.2K30,0000.2%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$8.9K710,0000.1%
Bristol-Myers Squibb Co(BMY)COM110122108$6.0K82,0000.1%
Harmony Biosciences Hldgs in(HRMY)COM413197104$5.8K120,0000.1%
Gilead Sciences Inc(GILD)COM375558103$5.8K98,0000.1%
Cigna Corp New(CI)COM125523100$5.8K24,0000.1%
Cardinal Health Inc(CAH)COM14149Y108$5.7K100,0000.1%
Utah MED Prods Inc(UTMD)COM917488108$5.0K56,0000.1%
LA Jolla Pharmaceutical Co(LJPC)COM503459604$3.0K707,0000.1%
Kempharm Inc(ZVRA)COM NEW488445206$1.3K255,0000.0%
Opiant Pharmaceuticals IncCOM683750103$38618,0000.0%